Details
Stereochemistry | ACHIRAL |
Molecular Formula | CH6O7P2 |
Molecular Weight | 192.0017 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(P(O)(O)=O)P(O)(O)=O
InChI
InChIKey=HJZKOAYDRQLPME-UHFFFAOYSA-N
InChI=1S/CH6O7P2/c2-1(9(3,4)5)10(6,7)8/h1-2H,(H2,3,4,5)(H2,6,7,8)
DescriptionSources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946a5d8-44bc-40d4-9b0e-b69c2ed6aec7Curator's Comment: description was created based on several sources, including
https://www.drugs.com/mmx/technetium-tc-99m-oxidronate.html
http://www2.mallinckrodt.com/Templates/Pages/productdetail.aspx?id=624
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946a5d8-44bc-40d4-9b0e-b69c2ed6aec7
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/mmx/technetium-tc-99m-oxidronate.html
http://www2.mallinckrodt.com/Templates/Pages/productdetail.aspx?id=624
Skeletal imaging, radionuclide—Technetium Tc 99m oxidronate is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget's disease, arthritic disease, osteomyelitis, and fractures. Technetium Tc 99m oxidronate injection is a radiopharmaceutical. Exact mechanism is not known. It is generally accepted that technetium Tc 99m oxidronate localizes on the surface of hydroxyapatite crystals by a process termed chemisorption, with blood flow and/or blood concentration being most important in the delivery of the agent to sites of uptake. Visualization of osseous lesions is possible since skeletal uptake of technetium Tc 99m oxidronate is altered in areas of abnormal osteogenesis. Rapidly distributed in and cleared from blood after intravenous administration, with about half the dose normally accumulating in the skeleton within 3 to 4 hours after injection. May also locate within infarcted myocardial cells or other regions of soft tissue necrosis or calcification. Minimal uptake by soft-tissue organs, except calcified cartilage, blood vessels, and kidneys. TechneScan HDP exhibits its greatest affinity for areas of altered osteogenesis and actively metabolizing bone. Some hypersensitivity reactions, as well as nausea and vomiting, have been infrequently associated with Technetium Tc 99m Oxidronate.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083042
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
SUB09525MIG
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
1306068
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
ALTERNATIVE | |||
|
71MR4V32TI
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
DTXSID10165699
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
m8309
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
C166976
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
15468-10-7
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
DB14159
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
3409
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
4727
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL1615775
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
27304
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
1546448
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY | |||
|
71MR4V32TI
Created by
admin on Fri Dec 15 15:18:49 GMT 2023 , Edited by admin on Fri Dec 15 15:18:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)